Perspective Therapeutics ... (CATX)
AMEX: CATX
· Real-Time Price · USD
3.27
0.10 (3.15%)
At close: Sep 24, 2025, 3:59 PM
3.31
1.38%
After-hours: Sep 24, 2025, 07:55 PM EDT
3.15% (1D)
| Bid | 3.17 |
| Market Cap | 242.44M |
| Revenue (ttm) | 576K |
| Net Income (ttm) | -113.64M |
| EPS (ttm) | -1.37 |
| PE Ratio (ttm) | -2.38 |
| Forward PE | -2.45 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 3.39 |
| Volume | 582,494 |
| Avg. Volume (20D) | 943,134.2 |
| Open | 3.18 |
| Previous Close | 3.17 |
| Day's Range | 3.18 - 3.32 |
| 52-Week Range | 1.60 - 13.56 |
| Beta | 1.21 |
| Ex-Dividend Date | n/a |
About CATX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CATX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CATX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsPerspective Therapeutics Inc. is scheduled to release its earnings on
Nov 11, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+29.29%
Perspective Therapeutics shares are trading higher...
Unlock content with
Pro Subscription
10 months ago
-51.38%
Perspective Therapeutics shares are trading lower. The company announced initial results from its ongoing Phase 1/2a clinical trial of [212Pb]VMT-α-NET.
